Massimo Di Maio/X
May 31, 2025, 07:48
Massimo Di Maio: Review on Interpreting Quality of Life Results in Cancer Trials
Massimo Di Maio, Associate Professor of Medical Oncology at Department of Oncology, University of Turin, shared a post on X:
“Have a look at my review seeking to help clinicians gain familiarity with the correct reading and interpretation of QoL results in cancer clinical trials, just published in NEJM Evidence”
Massimo Di Maio announced the publication of his review article in NEJM Evidence, which aims to support clinicians in properly interpreting quality of life (QoL) outcomes in cancer clinical trials. The review is intended as a practical guide for improving the understanding and application of QoL findings in oncology.
Reading and Interpreting Quality-of-Life Results in Cancer Trials
Authors: Massimo Di Maio
You can read the full article on NEJM Evidence
Read more posts by Massimo Di Maio on OncoDaily
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 31, 2025, 07:39
May 31, 2025, 07:32
May 31, 2025, 07:20
May 31, 2025, 07:14
May 31, 2025, 06:50
May 31, 2025, 06:42